You have 9 free searches left this month | for more free features.

Dulaglutide

Showing 1 - 25 of 111

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Type 2 Trial (Dulaglutide)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Dulaglutide
  • (no location specified)
Dec 20, 2022

Healthy Volunteers, Diabetes, Type 2, Overweight Trial in Groningen (Semaglutide, Dulaglutide)

Completed
  • Healthy Volunteers
  • +3 more
  • Groningen, Netherlands
    Novo Nordisk Investigational Site
Nov 4, 2022

Metabolic-associated Fatty Liver Disease, Type 2 Diabetes Trial (Empagliflozin, Dulaglutide, Empagliflozin and Dulaglutide)

Not yet recruiting
  • Metabolic-associated Fatty Liver Disease
  • Type 2 Diabetes
  • (no location specified)
Oct 1, 2022

T2DM (Type 2 Diabetes) Trial in Shanghai (Ecnoglutide high dosage, Ecnoglutide low dosage, Dulaglutide)

Not yet recruiting
  • T2DM (Type 2 Diabetes Mellitus)
  • Ecnoglutide high dosage
  • +3 more
  • Shanghai, Shanghai, China
    ZHONGSHAN Hospital
Dec 25, 2022

Novel Antidiabetic Medications and Their Effect on Liver

Completed
  • Non-Alcoholic Fatty Liver Disease
  • Liver Steatosis
  • Athens, Attiki, Greece
    "Hippocration" General Hospital of Athens
Jul 13, 2023

Type 2 Diabetes Trial in Beijing (dulaglutide, IBI362)

Not yet recruiting
  • Type 2 Diabetes
  • Beijing, China
    China-Japan Friendship Hospital
Nov 1, 2022

Type 2 Diabetes, Glucose, High Blood Trial in Cheonju (IGlarLixi, Dulaglutide)

Active, not recruiting
  • Type 2 Diabetes Mellitus
  • Glucose, High Blood
  • Cheonju, Chungcheongbuk-do, Korea, Republic of
    Chungbuk National University Hospital
Jul 19, 2022

Dulaglutide on Glycemic Variability in Type 2 Diabetes

Completed
  • Type 2 Diabetes
  • Dulaglutide 1.5 MG/ML
  • Shanghai, China
    180 Fenglin Road
Mar 30, 2022

Type 2 Diabetes Treated With Insulin, Obesity, Adolescent Obesity Trial in Lahore (Dulaglutide, Liraglutide)

Completed
  • Type 2 Diabetes Treated With Insulin
  • +2 more
  • Lahore, Punjab, Pakistan
    Zainab Khan
Mar 11, 2022

Type 2 Diabetes Trial in Zibo (14028 injection, dulaglutide injection)

Recruiting
  • Type 2 Diabetes
  • 14028 injection
  • dulaglutide injection
  • Zibo, Shandong, China
    PKUCare Luzhong Hospital
Jul 12, 2022

Polycystic Ovary Syndrome Trial in Shanghai (GLP-1 RAs, calorie restricted diet)

Completed
  • Polycystic Ovary Syndrome
  • GLP-1 RAs
  • calorie restricted diet
  • Shanghai, Shanghai, China
    Shanghai Tenth People' Hospital
Aug 2, 2022

Diabetes, Type 2 Trial in United States (LY3457263, Placebo, Dulaglutide)

Recruiting
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +4 more
Dec 8, 2022

Type 2 Diabetes Trial in Beijing (IBI362, , Dulaglutide)

Active, not recruiting
  • Type 2 Diabetes
  • Beijing, Beijing, China
    China Japan Friendship Hospital
Jul 15, 2022

Type 2 Diabetes Trial in Shijia Zhuang (TG103,Q2W, TG103,QW, Placebo,Q2W)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • Shijia Zhuang, Hebei, China
    Gao Huanhuan
Jun 9, 2022

Hyperglycemia Stress Trial in Atlanta (Dulaglutide, Placebo, Continuous glucose monitor (CGM), blinded)

Recruiting
  • Hyperglycemia Stress
  • Dulaglutide
  • +2 more
  • Atlanta, Georgia
  • +1 more
Dec 6, 2022

Cystic Fibrosis, Pancreatic Insufficiency, Abnormal Glucose Tolerance Trial in Philadelphia (Dulaglutide 0.75Mg/0.5Ml Inj Pen)

Recruiting
  • Cystic Fibrosis
  • +3 more
  • Dulaglutide 0.75Mg/0.5Ml Inj Pen
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 11, 2023

Type 2 Diabetes Trial in Beijing, Shijiazhuang (HEC88473, Placebo, Dulaglutide)

Recruiting
  • Type 2 Diabetes
  • HEC88473, Placebo, Dulaglutide
  • Beijing, Beijing, China
  • +1 more
Nov 20, 2023

Sexual Functioning Trial in Basel (Dulaglutide, Placebo)

Recruiting
  • Sexual Functioning
  • Dulaglutide
  • Placebo
  • Basel, Switzerland
    University Hospital Basel, Endocrinology, Diabetes and Metabolis
Mar 3, 2022

Diabetes, Diabetic Kidney Disease Trial in Sha Tin (Dulaglutide, Insulin Degludec, Continuous glucose monitor)

Recruiting
  • Diabetes Mellitus
  • Diabetic Kidney Disease
  • Dulaglutide
  • +2 more
  • Sha Tin, Hong Kong
    Prince of Wales Hospital
Nov 8, 2022

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Dulaglutide)

Recruiting
  • Type 2 Diabetes
  • Cooper City, Florida
  • +43 more
Jan 17, 2023

Diabetes, Type 2, Overweight or Obesity Trial in China (Beinaglutide, Dulaglutide)

Recruiting
  • Diabetes Mellitus, Type 2
  • Overweight or Obesity
  • Guangzhou, Guangdong, China
  • +3 more
Aug 25, 2021

Diabetes, Type 1, Endothelial Dysfunction Trial in Charlottesville (Dulaglutide, Placebo, exercise training)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Endothelial Dysfunction
  • Dulaglutide
  • +2 more
  • Charlottesville, Virginia
    University of Virginia
Jul 25, 2022

Diabetes, Diabetes, Type 2, Glucose Metabolism Disorders Trial in Japan (Dulaglutide, Biguanide (BG), Sulfonylurea (SU))

Active, not recruiting
  • Diabetes Mellitus
  • +6 more
  • Dulaglutide
  • +6 more
  • Nagoya-shi, Aichi, Japan
  • +43 more
Jan 16, 2023

Chronic Kidney Diseases Trial in Nashville (dulaglutide injection)

Recruiting
  • Chronic Kidney Diseases
  • dulaglutide injection
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Mar 20, 2022

Diabetes, Type 2 Trial in Anaheim, Miami, San Antonio (LY3493269, Dulaglutide, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Anaheim, California
  • +2 more
Apr 4, 2022